middle.news
Island Pharmaceuticals’ ISLA-101 Shows Promising Anti-Dengue Activity in Phase 2 Trial
10:11am on Thursday 12th of June, 2025 AEST
•
Healthcare
Read Story
Island Pharmaceuticals’ ISLA-101 Shows Promising Anti-Dengue Activity in Phase 2 Trial
10:11am on Thursday 12th of June, 2025 AEST
Key Points
ISLA-101 reduced viral load and symptoms in preventative cohort
Treatment cohort showed signals of drug effect on viral replication
Trial used a human challenge model with weakened dengue virus
Small sample size but results advocate continued clinical development
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
ILA
OPEN ARTICLE